- Home
- PYXS vs GECC Comparison
PYXS vs GECC Comparison
Compare PYXS & GECC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PYXS | GECC |
|---|---|---|
| Founded | 2018 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.6M | 69.0M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | PYXS | GECC |
|---|---|---|
| Price | $1.31 | $4.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $7.00 | ★ $10.75 |
| AVG Volume (30 Days) | ★ 281.8K | 143.4K |
| Earning Date | 03-23-2026 | 03-02-2026 |
| Dividend Yield | N/A | ★ 24.05% |
| EPS Growth | ★ 3.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,858,000.00 | N/A |
| Revenue This Year | N/A | $0.92 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.84 | $4.63 |
| 52 Week High | $5.55 | $11.45 |
Technical Indicators
Market Signals| Indicator | PYXS | GECC |
|---|---|---|
| Relative Strength Index (RSI) | 39.79 | 28.47 |
| Support Level | $1.29 | $4.63 |
| Resistance Level | $1.69 | $7.07 |
| Average True Range (ATR) | 0.11 | 0.24 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 11.90 | 20.57 |
Price Performance
Historical ComparisonAbout PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.
About GECC Great Elm Capital Corp.
Great Elm Capital Corp is an externally managed, non-diversified closed-end management investment company. It generates both income and capital appreciation through debt and income-generating equity investments, including investments in finance businesses. The Company operates as a single reportable segment with an investment objective to generate both current income and capital appreciation through debt and equity investments and manages the business on a consolidated basis.